Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

The pragmatism behind the WorkSafe reforms
Law & Regulation

Mike Mercer: The pragmatism behind the WorkSafe reforms

The greatest risk right now is not the reform itself, but how it is being received.

Will Paypal co-founder Max Levchin return?
Opinion

Robbie Paul: Will Paypal co-founder Max Levchin return?

The golden age of golden visas is dawning in New Zealand.

Robbie Paul 12 Jun 2025
The rise of 'vibe coding'
Opinion

Peter Griffin: The rise of 'vibe coding'

Vibe coding could become the most efficient way to prototype new products.

Peter Griffin 11 Jun 2025
Methane open letter's mistakes
Primary Sector

Adrian Macey and Dave Frame: Methane open letter's mistakes

No 'accounting trick' in the best measure for methane's climate impact.